Literature DB >> 11432596

In vitro release of heparin from silica xerogels.

M S Ahola1, E S Säilynoja, M H Raitavuo, M M Vaahtio, J I Salonen, A U Yli-Urpo.   

Abstract

Heparin, a powerful anticoagulant used for the prophylaxis of both surgical and medical thrombosis, was incorporated into a silica xerogel matrix during polycondensation of organic silicate. The influence of various chemical sol-gel parameters (the properties of reaction precursors, catalyst and final moisture content of the gel and heparin concentration) was studied. The release of heparin from the gel was according to zero order during the dissolution period and the release rate of heparin was proportional to the drug load in the concentration range between 6.8 and 13.6 wt%. It was found that the catalyst used for the preparation of the gel, the final moisture content and the chemical modification of silica xerogel network have an influence on the release rate of heparin. The released heparin from all the different xerogels studied retained about 90% of its biological activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11432596     DOI: 10.1016/s0142-9612(00)00407-5

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  7 in total

1.  Controlled release of small molecules from silica xerogel with limited nanoporosity.

Authors:  Rong Chen; Haibo Qu; Ashwin Agrawal; Shaoyun Guo; Paul Ducheyne
Journal:  J Mater Sci Mater Med       Date:  2012-10-10       Impact factor: 3.896

2.  Silica microparticles for sustained zero-order release of an anti-CD40L antibody.

Authors:  Puneet Tyagi; Mika Koskinen; Jari Mikkola; Lasse Leino; Alexander Schwarz
Journal:  Drug Deliv Transl Res       Date:  2018-04       Impact factor: 4.617

Review 3.  Recent advances and future perspectives of sol-gel derived porous bioactive glasses: a review.

Authors:  Kalim Deshmukh; Tomáš Kovářík; Tomáš Křenek; Denitsa Docheva; Theresia Stich; Josef Pola
Journal:  RSC Adv       Date:  2020-09-11       Impact factor: 4.036

4.  Silica xerogel-chitosan nano-hybrids for use as drug eluting bone replacement.

Authors:  Eun-Jung Lee; Shin-Hee Jun; Hyoun-Ee Kim; Hae-Won Kim; Young-Hag Koh; Jun-Hyeog Jang
Journal:  J Mater Sci Mater Med       Date:  2009-08-06       Impact factor: 3.896

5.  Sustained release of hepatocyte growth factor by cationic self-assembling peptide/heparin hybrid hydrogel improves β-cell survival and function through modulating inflammatory response.

Authors:  Shuyun Liu; Lanlan Zhang; Jingqiu Cheng; Yanrong Lu; Jingping Liu
Journal:  Int J Nanomedicine       Date:  2016-09-23

6.  Multi-component hybrid hydrogels - understanding the extent of orthogonal assembly and its impact on controlled release.

Authors:  Vânia M P Vieira; Laura L Hay; David K Smith
Journal:  Chem Sci       Date:  2017-08-24       Impact factor: 9.825

7.  Heparin nanomodification improves biocompatibility and biomechanical stability of decellularized vascular scaffolds.

Authors:  Yunming Tao; Tiehui Hu; Zhongshi Wu; Hao Tang; Yerong Hu; Qi Tan; Chunlin Wu
Journal:  Int J Nanomedicine       Date:  2012-11-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.